UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Placental transfer of the integrase strand inhibitors cabotegravir and bictegravir in the ex-vivo human cotyledon perfusion model

AIDS (London), 2020-11, Vol.34 (14), p.2145-2149

2020

Volltextzugriff (PDF)

Identifying lithium‐poisoned patients who may benefit from haemodialysis remains highly challenging

British journal of clinical pharmacology, 2020-12, Vol.86 (12), p.2542-2543

2020

Volltextzugriff (PDF)

HIV-1 RNA Kinetics in Blood Plasma and in Seminal Plasma of Men Starting a Dolutegravir-Based Triple-Combination Regimen at the Time of Primary HIV-1 Infection

The Journal of infectious diseases, 2022-01, Vol.225 (1), p.116-120

2022

Volltextzugriff (PDF)

M184V/I does not impact the efficacy of abacavir/lamivudine/dolutegravir use as switch therapy in virologically suppressed patients

Journal of antimicrobial chemotherapy, 2020-05, Vol.75 (5), p.1290-1293

2020

Volltextzugriff (PDF)

Impact of Loading Dose of Caspofungin in Pharmacokinetic-Pharmacodynamic Target Attainment for Severe Candidiasis Infections in Patients in Intensive Care Units: the CASPOLOAD Study

Antimicrobial agents and chemotherapy, 2020-11, Vol.64 (12)

2020

Volltextzugriff (PDF)

Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19

The Journal of infection, 2021-01, Vol.82 (1), p.159-198

2021

Volltextzugriff (PDF)

Failure of hydroxychloroquine pre-exposure prophylaxis in COVID-19 infection? A case report

Journal of antimicrobial chemotherapy, 2020-09, Vol.75 (9), p.2706-2707

2020

Volltextzugriff (PDF)

Doravirine Exposure Decreased by Dialysis in a HIV Patient: A Grand Round

Therapeutic drug monitoring, 2023-04, Vol.45 (2), p.133-135

2023

Volltextzugriff (PDF)

High virological suppression regardless of the genotypic susceptibility score after switching to a dolutegravir-based regimen: week 48 results in an observational cohort

Journal of antimicrobial chemotherapy, 2018-06, Vol.73 (6), p.1665-1671

2018

Volltextzugriff (PDF)

Penetration and antiviral efficacy of total and unbound maraviroc, raltegravir and rilpivirine in both female and male genital fluids from HIV-positive patients receiving regimens containing these antiretrovirals

Journal of antimicrobial chemotherapy, 2017-11, Vol.72 (11), p.3167-3171

2017

Volltextzugriff (PDF)

Dabigatran-reversal failure using standard dose of idarucizumab: a systematic review and meta-analysis of cases

Research and practice in thrombosis and haemostasis, 2023-07, Vol.7 (5), p.100201-100201, Article 100201

2023

Volltextzugriff (PDF)

Once‐daily darunavir/ritonavir 400/100 mg in triple therapy: efficacy and penetration in seminal compartment in ANRS‐165 DARULIGHT study

British journal of clinical pharmacology, 2019-01, Vol.85 (1), p.277-280

2019

Volltextzugriff (PDF)

Sialolithiasis in an HIV-1-infected patient treated with atazanavir/ritonavir monotherapy

Journal of antimicrobial chemotherapy, 2013-03, Vol.68 (3), p.727-729

2013

Volltextzugriff (PDF)

Serious neuropsychiatric adverse effects in a hepatitis C virus/hepatitis B virus/HIV-coinfected patient receiving bosentan and telaprevir

Journal of antimicrobial chemotherapy, 2013-05, Vol.68 (5), p.1208-1209

2013

Volltextzugriff (PDF)

Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study

Journal of antimicrobial chemotherapy, 2017-04, Vol.72 (4), p.1137-1146

2017

Volltextzugriff (PDF)

Letermovir for CMV Prophylaxis in Very High-Risk Pediatric Hematopoietic Stem Cell Transplantation Recipients for Inborn Errors of Immunity

Journal of clinical immunology, 2024-01, Vol.44 (1), p.6-6, Article 6

2024

Volltextzugriff (PDF)

Pharmaco‐virological algorithm to target risk of drug resistance among a population of HIV‐infected key populations in Togo

Journal of medical virology, 2023-02, Vol.95 (2), p.e28535-n/a

2023

Volltextzugriff (PDF)

Pharmacovirological analyses of blood and male genital compartment in patients receiving dolutegravir + lamivudine dual therapy as a switch strategy (ANRS 167 LAMIDOL trial)

Journal of antimicrobial chemotherapy, 2020-06, Vol.75 (6), p.1611-1617

2020

Volltextzugriff (PDF)

Pharmacokinetics, safety and efficacy of ritonavir-boosted atazanavir (300/100 mg once daily) in HIV-1-infected pregnant women

Antiviral therapy, 2015-01, Vol.20 (5), p.507-513

2015

Volltextzugriff (PDF)

Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV‐1‐infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS‐MIE‐BIRIDER study)

British journal of clinical pharmacology, 2024-01, Vol.90 (1), p.264-273

2024

Volltextzugriff (PDF)

Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi: a prospective cohort study

The lancet HIV, 2022-08, Vol.9 (8), p.e544-e553

2022

Volltextzugriff (PDF)

Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study

Journal of antimicrobial chemotherapy, 2018-08, Vol.73 (8), p.2120-2128

2018

Volltextzugriff (PDF)

Allosteric Modulation of Binding Properties between Units of Chemokine Receptor Homo- and Hetero-Oligomers

Molecular pharmacology, 2006-05, Vol.69 (5), p.1652-1661

2006

Volltextzugriff (PDF)

Novel CagA ELISA exhibits enhanced sensitivity of Helicobacter pylori CagA antibody

World journal of gastroenterology : WJG, 2017-01, Vol.23 (1), p.48-59

2017

Volltextzugriff (PDF)

Characterization of the Thermoneutral Zone of the Laboratory Rat

The FASEB journal, 2008-03, Vol.22 (S1)

2008

Volltextzugriff (PDF)

1 – 25 von 676

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(535)
Mit Volltextzugriff
(547)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Placental transfer of the integrase strand inhibitors cabotegravir and bictegravir in the ex-vivo human cotyledon perfusion model

Identifying lithium‐poisoned patients who may benefit from haemodialysis remains highly challenging

HIV-1 RNA Kinetics in Blood Plasma and in Seminal Plasma of Men Starting a Dolutegravir-Based Triple-Combination Regimen at the Time of Primary HIV-1 Infection

M184V/I does not impact the efficacy of abacavir/lamivudine/dolutegravir use as switch therapy in virologically suppressed patients

Impact of Loading Dose of Caspofungin in Pharmacokinetic-Pharmacodynamic Target Attainment for Severe Candidiasis Infections in Patients in Intensive Care Units: the CASPOLOAD Study

Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19

Failure of hydroxychloroquine pre-exposure prophylaxis in COVID-19 infection? A case report

Doravirine Exposure Decreased by Dialysis in a HIV Patient: A Grand Round

High virological suppression regardless of the genotypic susceptibility score after switching to a dolutegravir-based regimen: week 48 results in an observational cohort

Penetration and antiviral efficacy of total and unbound maraviroc, raltegravir and rilpivirine in both female and male genital fluids from HIV-positive patients receiving regimens containing these antiretrovirals

Dabigatran-reversal failure using standard dose of idarucizumab: a systematic review and meta-analysis of cases

Once‐daily darunavir/ritonavir 400/100 mg in triple therapy: efficacy and penetration in seminal compartment in ANRS‐165 DARULIGHT study

Sialolithiasis in an HIV-1-infected patient treated with atazanavir/ritonavir monotherapy

Serious neuropsychiatric adverse effects in a hepatitis C virus/hepatitis B virus/HIV-coinfected patient receiving bosentan and telaprevir

Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study

Letermovir for CMV Prophylaxis in Very High-Risk Pediatric Hematopoietic Stem Cell Transplantation Recipients for Inborn Errors of Immunity

Pharmaco‐virological algorithm to target risk of drug resistance among a population of HIV‐infected key populations in Togo

Pharmacovirological analyses of blood and male genital compartment in patients receiving dolutegravir + lamivudine dual therapy as a switch strategy (ANRS 167 LAMIDOL trial)

Pharmacokinetics, safety and efficacy of ritonavir-boosted atazanavir (300/100 mg once daily) in HIV-1-infected pregnant women

Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV‐1‐infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS‐MIE‐BIRIDER study)

Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi: a prospective cohort study

Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study

Allosteric Modulation of Binding Properties between Units of Chemokine Receptor Homo- and Hetero-Oligomers

Novel CagA ELISA exhibits enhanced sensitivity of Helicobacter pylori CagA antibody

Characterization of the Thermoneutral Zone of the Laboratory Rat

Suchergebnisse filtern